NEUROGEN DIRECT Trademark
Trademark Overview
On Wednesday, April 9, 2025, a trademark application was filed for NEUROGEN DIRECT with the United States Patent and Trademark Office. The USPTO has given the NEUROGEN DIRECT trademark a serial number of 99128124. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Thursday, January 15, 2026. This trademark is owned by Neurogen Biomarking, LLC. The NEUROGEN DIRECT trademark is filed in the Advertising, Business and Retail Services and Medical & Beauty Services & Agricultural Services categories with the following description:
Maintaining a registry of primary care physicians who meet established standards for understanding and utilizing specialized screening test kits; business administrative services for medical referrals featuring primary care physicians trained in the use of screening services for neurological disease indicators
Providing an online computer database featuring health information pertaining to primary care physicians who meet established standards for understanding and utilizing specialized screening test kits
General Information
| Serial Number | 99128124 |
| Word Mark | NEUROGEN DIRECT |
| Filing Date | Wednesday, April 9, 2025 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Thursday, January 15, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Maintaining a registry of primary care physicians who meet established standards for understanding and utilizing specialized screening test kits; business administrative services for medical referrals featuring primary care physicians trained in the use of screening services for neurological disease indicators |
| NOT AVAILABLE | DIRECT |
| Goods and Services | Providing an online computer database featuring health information pertaining to primary care physicians who meet established standards for understanding and utilizing specialized screening test kits |
Classification Information
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, January 15, 2026 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, April 9, 2025 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Neurogen Biomarking, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Dover, DE 19901 |
Trademark Events
| Event Date | Event Description |
| Wednesday, April 9, 2025 | NEW APPLICATION ENTERED |
| Wednesday, April 9, 2025 | APPLICATION FILING RECEIPT MAILED |
| Friday, July 11, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, September 4, 2025 | ASSIGNED TO EXAMINER |
| Tuesday, October 21, 2025 | NON-FINAL ACTION WRITTEN |
| Tuesday, October 21, 2025 | NON-FINAL ACTION E-MAILED |
| Tuesday, October 21, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, January 15, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, January 15, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, January 15, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
